clinical trial · NCT07465731
A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase1·completed·n = 62
Healthy VolunteersCentanafadine SRCentanafadine QD XR
brief summary
The purpose of this trial is to assess relative bioavailability of centanafadine (CTN) SR tablet to CTN QD XR capsule in healthy adult participants.
started
Oct 27, 2022
primary completion
Mar 26, 2023
completion
Mar 26, 2023
last updated
Mar 12, 2026
official title
A Phase 1, Randomized, Open-label, Parallel-arm Trial to Assess Relative Bioavailability of Centanafadine Sustained-Release (SR) Tablet to Once-Daily Extended-Release (QD XR) Capsule Following Oral Administration in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol